{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:09:24Z","timestamp":1793045364577,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08 HL133381"],"award-info":[{"award-number":["K08 HL133381"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jaip.2021.12.034","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T12:19:19Z","timestamp":1642076359000},"page":"742-750.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Joe G.","family":"Zein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy H.","family":"Attaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Milinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen","family":"Jawhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soulaima S.","family":"Chamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.12.034_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaip.2021.12.034_bib2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.12.034_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2021.12.034_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.05.004","article-title":"Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells","volume":"146","author":"Kimura","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.05.051","article-title":"Expression of SARS-CoV-2 receptor ACE2 and coincident host response signature varies by asthma inflammatory phenotype","volume":"146","author":"Camiolo","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib6","article-title":"Clinical outcome of eosinophilia in patients with COVID-19: a controlled study","volume":"91","author":"Nair","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.jaip.2021.12.034_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/microorganisms9020334","article-title":"Do blood eosinophils predict in-hospital mortality or severity of disease in SARS-CoV-2 infection? A retrospective multicenter study","volume":"9","author":"Le Borgne","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jaip.2021.12.034_bib8","article-title":"Eosinophilia in asthma patients is protective against severe COVID-19 illness","volume":"9","author":"Ferastraoaru","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.034_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.anai.2021.02.021","article-title":"The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection","volume":"127","author":"Ho","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib10","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210582","article-title":"Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19","volume":"218","author":"Wilk","year":"2021","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A\u00a0single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13073-020-00823-5","article-title":"Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients","volume":"13","author":"Aschenbrenner","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2021.12.034_bib16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaip.2021.12.034_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2021.12.034_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.202003-0821OC","article-title":"COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.09.034","article-title":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon","volume":"147","author":"Finney","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/JVI.01648-20","article-title":"The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells","volume":"95","author":"Matsuyama","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaip.2021.12.034_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2020.12.001","article-title":"Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2","volume":"554","author":"Zhang","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.jaip.2021.12.034_bib23","article-title":"Intranasal corticosteroids are associated with better outcomes in coronavirus disease 2019 (COVID-19)","volume":"9","author":"Strauss","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.034_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.06.010","article-title":"Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19","volume":"146","author":"Chhiba","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib25","doi-asserted-by":"crossref","first-page":"2003142","DOI":"10.1183\/13993003.03142-2020","article-title":"The impact of COVID-19 on patients with asthma","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.12.034_bib26","doi-asserted-by":"crossref","first-page":"2001009","DOI":"10.1183\/13993003.01009-2020","article-title":"Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective","volume":"55","author":"Halpin","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.12.034_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S2213-2600(20)30447-1","article-title":"Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?","volume":"8","author":"Singh","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib29","doi-asserted-by":"crossref","first-page":"100515","DOI":"10.1016\/j.eclinm.2020.100515","article-title":"SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: an analysis of Cleveland clinic's COVID-19 registry","volume":"26","author":"Attaway","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2021.12.034_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamainternmed.2020.8360","article-title":"Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 Registry","volume":"181","author":"Lowe","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib31","first-page":"1","article-title":"Safety of influenza vaccine during COVID-19","volume":"5","author":"Zein","year":"2020","journal-title":"J\u00a0Clin Transl Sci"},{"key":"10.1016\/j.jaip.2021.12.034_bib32","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaip.2021.12.034_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/atm.2018.01.13","article-title":"Extracting and utilizing electronic health data from Epic for research","volume":"6","author":"Milinovich","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.12.034_bib35","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","article-title":"Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma","volume":"11","author":"Katz","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2021.12.034_bib37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmii.2020.12.005","article-title":"Eosinopenia <100\/muL as a marker of active COVID-19: an observational prospective study","volume":"54","author":"Outh","year":"2021","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jaip.2021.12.034_bib40","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12788\/jhm.3552","article-title":"Trends in COVID-19 risk-adjusted mortality rates","volume":"16","author":"Horwitz","year":"2021","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/CCM.0000000000004747","article-title":"Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020","volume":"49","author":"Dennis","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib43","first-page":"1","article-title":"mice: Multivariate Imputation by Chained Equations in R","volume":"45","author":"Van Buuren","year":"2011","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jaip.2021.12.034_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12026-008-8058-5","article-title":"Eosinophils and their interactions with respiratory virus pathogens","volume":"43","author":"Rosenberg","year":"2009","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaip.2021.12.034_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2015-0405OC","article-title":"Human and mouse eosinophils have antiviral activity against parainfluenza virus","volume":"55","author":"Drake","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2021.12.034_bib46","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaip.2021.12.034_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1165\/rcmb.2006-0457OC","article-title":"Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils","volume":"37","author":"Wong","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2021.12.034_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/vim.2018.0150","article-title":"Eosinophils and respiratory viruses","volume":"32","author":"Flores-Torres","year":"2019","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib49","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.171.8.3977","article-title":"Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand","volume":"171","author":"Nagase","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib50","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.190.10.1465","article-title":"Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects","volume":"190","author":"Adamko","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13073-021-00866-2","article-title":"Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium","volume":"13","author":"Kasela","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1513\/pats.200402-004MS","article-title":"Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung diseases","volume":"1","author":"Georas","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jaip.2021.12.034_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.04.021","article-title":"Eosinophil responses during COVID-19 infections and coronavirus vaccination","volume":"146","author":"Lindsley","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib55","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41379-020-00661-1","article-title":"COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City","volume":"33","author":"Borczuk","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2021.12.034_bib56","article-title":"The relationship of asthma severity to COVID-19 outcomes","volume":"10","author":"Zein","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.12.034_bib57","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00705-016-2904-x","article-title":"Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responses","volume":"161","author":"Abdul-Cader","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.jaip.2021.12.034_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in\u00a0vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaip.2021.12.034_bib59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.12.1009","article-title":"Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids","volume":"143","author":"Peters","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.12.034_bib61","doi-asserted-by":"crossref","first-page":"100515","DOI":"10.1016\/j.eclinm.2020.100515","article-title":"SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: an analysis of Cleveland clinic's COVID-19 registry","volume":"26","author":"Attaway","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2021.12.034_bib62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamainternmed.2020.8360","article-title":"Association of smoking and cumulative pack-year exposure with COVID-19 outcomes in the Cleveland Clinic COVID-19 Registry","volume":"181","author":"Lowe","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib63","first-page":"1","article-title":"Safety of influenza vaccine during COVID-19","volume":"5","author":"Zein","year":"2020","journal-title":"J\u00a0Clin Transl Sci"},{"key":"10.1016\/j.jaip.2021.12.034_bib64","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaip.2021.12.034_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/atm.2018.01.13","article-title":"Extracting and utilizing electronic health data from Epic for research","volume":"6","author":"Milinovich","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib66","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.12.034_bib67","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the Seattle region - case series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib68","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"172","author":"Lauer","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2021.12.034_bib70","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2021.12.034_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmii.2020.12.005","article-title":"Eosinopenia <100\/muL as a marker of active COVID-19: an observational prospective study","volume":"54","author":"Outh","year":"2021","journal-title":"J\u00a0Microbiol Immunol Infect"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:33:41Z","timestamp":1761975221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213219822000095"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.12.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}